Joyner is a professor in the Department of Anesthesiology and Perioperative Medicine at the Mayo Clinic and led the U.S. Expanded Access Program for Convalescent Plasma. Wright is a professor of ...

Convalescent plasma – a once-celebrated treatment for COVID-19 that has largely fallen out of favor – does work well for people who are immune-compromised, according to a study published Thursday.The ...

Convalescent plasma may be another tool to help prevent coronavirus infections sparked by the omicron variant from turning severe if patients receive it soon after developing symptoms, according to ...

One potential treatment for COVID-19, known as convalescent plasma, may be derived from patients who have already recovered from the disease, and the US Food and Drug Administration (FDA) said Tuesday ...

Convalescent plasma was one of the first treatments created at the start of the pandemic in an attempt to help the seriously ill. But the WHO now says evidence shows convalescent plasma doesn't ...

Guidance for industry on the use of convalescent plasma for patients with COVID-19 has been updated to reflect the 23 August Emergency Use Authorization (EUA) for the investigational product. The ...

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent ...

Please provide your email address to receive an email when new articles are posted on . Compared with placebo, convalescent plasma with neutralizing anti-SARS-CoV-2 antibodies showed no improvement in ...

The recently identified Omicron variant is the cause behind a surge of coronavirus disease 2019 (COVID-19) cases and hospitalizations in the last few months of 2021. While Omicron infects both ...